title: Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).
authors.forename: Gordon J S
authors.initials: GJ
authors.lastname: Rustin
authors.forename: Michael
authors.initials: M
authors.lastname: Quinn
authors.forename: Tate
authors.initials: T
authors.lastname: Thigpen
authors.forename: Andreas
authors.initials: A
authors.lastname: du Bois
authors.forename: Eric
authors.initials: E
authors.lastname: Pujade-Lauraine
authors.forename: Anders
authors.initials: A
authors.lastname: Jakobsen
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Eisenhauer
authors.forename: Satoru
authors.initials: S
authors.lastname: Sagae
authors.forename: Kathryn
authors.initials: K
authors.lastname: Greven
authors.forename: Ignace
authors.initials: I
authors.lastname: Vergote
authors.forename: Andres
authors.initials: A
authors.lastname: Cervantes
authors.forename: Jan
authors.initials: J
authors.lastname: Vermorken
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D018394:CA-125 Antigen / Q000097:blood*; D005260:Female; D006801:Humans; D007391:International Cooperation; D010051:Ovarian Neoplasms / Q000276:immunology* / Q000628:therapy*; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D018394:CA-125 Antigen